Neuropace Inc (NPCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,465 | -18,736 | -15,240 | -6,589 | -27,141 |
| Depreciation Amortization | 2,185 | 332 | 1,043 | 98 | 1,997 |
| Accounts receivable | -1,830 | -2,087 | -704 | -2,585 | -536 |
| Accounts payable and accrued liabilities | -730 | 1,655 | 1,703 | 966 | 671 |
| Other Working Capital | -4,012 | -2,681 | -2,278 | -3,958 | -5,452 |
| Other Operating Activity | 14,846 | 10,005 | 5,908 | 4,586 | 12,512 |
| Operating Cash Flow | $-11,006 | $-11,512 | $-9,568 | $-7,482 | $-17,949 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 0 | 0 | N/A | 9,300 |
| PPE Investments | -332 | -235 | -205 | -37 | -306 |
| Investing Cash Flow | $-332 | $-235 | $-205 | $-37 | $8,994 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 58,435 | 58,435 | 58,568 | N/A | N/A |
| Debt Repayment | -60,507 | -60,507 | -60,507 | N/A | N/A |
| Common Stock Issued | 71,761 | 71,038 | 71,087 | 70,882 | 5,208 |
| Common Stock Repurchased | -49,546 | -49,546 | -49,546 | -49,546 | N/A |
| Other Financing Activity | -543 | -455 | -402 | -228 | -881 |
| Financing Cash Flow | $19,600 | $18,965 | $19,200 | $21,108 | $4,327 |
| Beginning Cash Position | 13,552 | 13,552 | 13,552 | 13,552 | 18,180 |
| End Cash Position | 21,814 | 20,770 | 22,979 | 27,141 | 13,552 |
| Net Cash Flow | $8,262 | $7,218 | $9,427 | $13,589 | $-4,628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,006 | -11,512 | -9,568 | -7,482 | -17,949 |
| Capital Expenditure | -332 | -235 | -205 | -37 | -306 |
| Free Cash Flow | -11,338 | -11,747 | -9,773 | -7,519 | -18,255 |